Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding investing ideas ...

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

Genmab presents a long-term investment opportunity, but uncertainties around Darzalex's pending patent expiration warrant a ...

Cancer treatments can instigate ocular surface disease and other deleterious ocular side effects that optometrists can oversee and manage.

Discover AbbVie's strong performance, with immunology growth and undervaluation despite challenges. Click here to read an ...

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. | ...

Epsilogen has acquired antibody developer TigaTx in a deal that collates work from the companies’ alternative antibody ...

What should investors do when stocks are tanking over the short term? Three Motley Fool contributors think they've found ...

These deals added major growth drivers to the company's lineup, including cancer drug Elahere, cosmetic therapy Botox, and antipsychotic Vraylar. In addition, AbbVie's pipeline appears to be ...

After underperforming the overall market for the past few years, large-cap pharmaceutical stocks may now be positioned to outperform as the impact of tariffs on foreign products and services ...